#None #Geneva #Caring Cross #Advanced Therapies #HIEx

Caring Cross and HIEx Launch Advanced Therapies Initiative

In a significant stride towards enhancing healthcare accessibility, Caring Cross has announced a collaboration with the Health Innovation Exchange (HIEx) to introduce the Advanced Therapies Caring Cross (ATCX) initiative. This initiative is primarily designed to improve access to advanced medical treatments for cancer and chronic diseases in low- and middle-income countries (LMICs). The official unveiling took place during the World Health Assembly's side event titled "Accelerating Advanced Medical Technology Innovations for Equitable Health," set to occur on May 20, 2025, in Geneva.

A Vision for Affordable Healthcare

The ATCX initiative aims to address persistent gaps in healthcare access, particularly in oncology and mental health. As outlined by Dr. Boro Dropulic, Executive Director of Caring Cross, the creation of this initiative is a vital move towards developing sustainable and locally driven solutions to make advanced therapies not just effective but also scalable and affordable. By situating ATCX within the Sigmastack Climate Health impact investing platform, both organizations pledge to ensure these therapies are accessible to all communities, irrespective of their geographical or economic standing.

Funding and Technical Assistance

The ATCX will function as a dedicated segment of the Sigmastack platform, which itself is composed of an ambitious open-ended investment fund targeting up to USD 500 million over the following decade, aimed at fostering advancements in health. Complementing the fund is a specialized Technical Assistance (TA) facility enhanced by catalytic grants contributing 5% of the fund's capital to minimize investment risks. This support will nurture innovative business designs while fostering collaboration between corporate partners, investors, and public health entities.

Key Discussions at the Launch Event

The upcoming launch event is poised to attract an array of global health leaders, innovators, and policy-makers. Topics slated for discussion include:

• - Addressing the oncology access gap in LMICs
• - Exploring models for affordable advanced cancer therapies
• - Bridging patient-centered innovation with health equity
• - The transformative potential of AI and neurotechnology in global mental health systems

This event signifies a crucial collaborative effort in the health sector to better the landscapes of healthcare in underserved regions, combining innovation with investment to produce tangible results.

Profile of Caring Cross

Caring Cross operates as a 501(c)(3) non-profit organization devoted to propelling the development and accessibility of advanced medical solutions globally. Through innovative therapeutic candidates, they strive to enhance the affordability and applicability of advanced medical treatments, such as CAR-T therapy and stem cell gene therapy. By employing Vector BioMed’s high-quality lentiviral vector manufacturing solutions, they ensure these advanced therapies are within reach of those who need them most.

For more insights about the endeavor, visit Caring Cross and learn about Vector BioMed's contributions here.

The partnership with HIEx also denotes a significant alignment with innovative strategies aimed at revitalizing healthcare delivery in low-income nations. HIEx is committed to uniting policymakers, innovators, and investors to foster impactful health solutions worldwide.

Through these combined efforts, Caring Cross and HIEx strive to pave a better path towards equitable health for all individuals, showcasing the power of collaboration in creating a healthier future for underserved populations.